Insider · CIK 0001181175

FRAZIER KENNETH C

Reports to the SEC for 5 companies · MILLBRAE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001181175

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-02	EIKNEikon Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25.9K sh	—	—	25,873
2026-02-04	EIKNEikon Therapeutics, Inc.P Purchase	Director	PPurchase	+111K sh	$18.00	+$2M	111,111
2022-11-07	MRKMerck & Co., Inc.M Exercise/Conversion	Director, Executive Chair	MExercise/Conversion	+236K sh	—	—	936,422.063
2022-11-07	MRKMerck & Co., Inc.S Sale	Director, Executive Chair	SSale	−126K sh	$99.42	−$12.5M	785,374.063
2022-11-07	MRKMerck & Co., Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Executive Chair	MExercise/Conversion	−236K sh	—	—	0
2022-11-07	MRKMerck & Co., Inc.S Sale	Director, Executive Chair	SSale	−84.7K sh	$100.07	−$8.48M	700,653.063
2022-11-07	MRKMerck & Co., Inc.S Sale	Director, Executive Chair	SSale	−24.9K sh	$98.45	−$2.45M	911,508.063
2022-11-04	MRKMerck & Co., Inc.S Sale	Director, Executive Chair	SSale	−34.8K sh	$99.08	−$3.45M	700,653.063
2022-11-04	MRKMerck & Co., Inc.S Sale	Director, Executive Chair	SSale	−200K sh	$98.53	−$19.7M	735,463.063
2022-11-04	MRKMerck & Co., Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Executive Chair	MExercise/Conversion	−235K sh	—	—	235,769
2022-11-04	MRKMerck & Co., Inc.M Exercise/Conversion	Director, Executive Chair	MExercise/Conversion	+235K sh	—	—	935,653.063
2022-11-03	MRKMerck & Co., Inc.M Exercise/Conversion	Director, Executive Chair	MExercise/Conversion	+235K sh	—	—	935,653.063
2022-11-03	MRKMerck & Co., Inc.S Sale	Director, Executive Chair	SSale	−215K sh	$98.68	−$21.2M	721,036.063
2022-11-03	MRKMerck & Co., Inc.S Sale	Director, Executive Chair	SSale	−20.4K sh	$99.09	−$2.02M	700,653.063
2022-11-03	MRKMerck & Co., Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Executive Chair	MExercise/Conversion	−235K sh	—	—	470,769
2022-11-02	MRKMerck & Co., Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Executive Chair	MExercise/Conversion	−134K sh	—	—	705,769
2022-11-02	MRKMerck & Co., Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Executive Chair	MExercise/Conversion	−166K sh	—	—	0
2022-11-02	MRKMerck & Co., Inc.S Sale	Director, Executive Chair	SSale	−94.3K sh	$100.40	−$9.47M	700,653.063
2022-11-02	MRKMerck & Co., Inc.S Sale	Director, Executive Chair	SSale	−206K sh	$99.68	−$20.5M	794,992.063
2022-11-02	MRKMerck & Co., Inc.M Exercise/Conversion	Director, Executive Chair	MExercise/Conversion	+134K sh	—	—	1,000,653.063
2022-11-02	MRKMerck & Co., Inc.M Exercise/Conversion	Director, Executive Chair	MExercise/Conversion	+166K sh	—	—	866,481.063
2022-11-01	MRKMerck & Co., Inc.G Gift	Director, Executive Chair	GGift	−1,470 sh	—	—	700,653.063
2022-11-01	MRKMerck & Co., Inc.G Gift	Director, Executive Chair	GGift	−2,450 sh	—	—	702,123.063
2022-11-01	MRKMerck & Co., Inc.G Gift	Director, Executive Chair	GGift	−1,710 sh	—	—	704,573.063
2022-11-01	MRKMerck & Co., Inc.S Sale	Director, Executive Chair	SSale	−700 sh	$101.05	−$70.7K	706,283.063
2022-11-01	MRKMerck & Co., Inc.S Sale	Director, Executive Chair	SSale	−97K sh	$100.22	−$9.72M	706,983.063
2022-11-01	MRKMerck & Co., Inc.S Sale	Director, Executive Chair	SSale	−202K sh	$99.61	−$20.2M	803,964.063
2022-11-01	MRKMerck & Co., Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Executive Chair	MExercise/Conversion	−300K sh	—	—	165,828
2022-11-01	MRKMerck & Co., Inc.M Exercise/Conversion	Director, Executive Chair	MExercise/Conversion	+300K sh	—	—	1,006,283.063
2022-10-31	MRKMerck & Co., Inc.S Sale	Director, Executive Chair	SSale	−229K sh	$101.03	−$23.2M	706,283.063
2022-10-31	MRKMerck & Co., Inc.S Sale	Director, Executive Chair	SSale	−70.7K sh	$99.82	−$7.06M	935,585.063
2022-10-31	MRKMerck & Co., Inc.M Exercise/Conversion	Director, Executive Chair	MExercise/Conversion	+300K sh	—	—	1,006,283.063
2022-10-31	MRKMerck & Co., Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Executive Chair	MExercise/Conversion	−300K sh	—	—	465,828
2022-10-28	MRKMerck & Co., Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Executive Chair	MExercise/Conversion	−567K sh	—	—	0
2022-10-28	MRKMerck & Co., Inc.S Sale	Director, Executive Chair	SSale	−178K sh	$100.80	−$18M	706,283.063
2022-10-28	MRKMerck & Co., Inc.S Sale	Director, Executive Chair	SSale	−313K sh	$100.25	−$31.4M	884,646.063
2022-10-28	MRKMerck & Co., Inc.S Sale	Director, Executive Chair	SSale	−75.5K sh	$99.15	−$7.48M	1,197,878.063
2022-10-28	MRKMerck & Co., Inc.M Exercise/Conversion	Director, Executive Chair	MExercise/Conversion	+567K sh	—	—	1,273,367.063
2022-08-03	MRKMerck & Co., Inc. · Restricted Stock UnitA Award	Director, Executive Chair	AAward	+28.5K sh	—	—	28,532
2022-05-03	MRKMerck & Co., Inc. · Restricted Stock UnitA Award	Director, Executive Chair	AAward	+28.7K sh	—	—	28,703
2022-02-24	MRKMerck & Co., Inc.A Award	Director, Executive Chair	AAward	+119K sh	$73.51	+$8.78M	706,283.063
2022-01-03	EXXON MOBIL CORPA Award	Director	AAward	+2,500 sh	—	—	40,500
2021-11-09	MRKMerck & Co., Inc.S Sale	Director, Executive Chair	SSale	−29.6K sh	$83.23	−$2.46M	586,795.063
2021-11-09	MRKMerck & Co., Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Executive Chair	MExercise/Conversion	−664K sh	—	—	0
2021-11-09	MRKMerck & Co., Inc.S Sale	Director, Executive Chair	SSale	−634K sh	$82.22	−$52.1M	616,410.063
2021-11-09	MRKMerck & Co., Inc.M Exercise/Conversion	Director, Executive Chair	MExercise/Conversion	+664K sh	—	—	1,250,676.063
2021-05-04	MRKMerck & Co., Inc. · Stock Option (Right to Buy)A Award	Director, Executive Chair	AAward	+329K sh	—	—	329,082
2021-02-26	MRKMerck & Co., Inc.A Award	Director, Executive Chair	AAward	+175K sh	$72.62	+$12.7M	586,795.063
2021-01-04	EXXON MOBIL CORPA Award	Director	AAward	+2,500 sh	—	—	38,000
2020-11-09	MRKMerck & Co., Inc.S Sale	Director, Executive Chair	SSale	−135K sh	$81.08	−$11M	556,412.063

Recent filings

Accepted (ET)
Mar 44
FRAZIER KENNETH C0001193125-26-091783
SEC(opens sec.gov)
Feb 64
FRAZIER KENNETH C0001193125-26-041555
SEC(opens sec.gov)
Nov 84
FRAZIER KENNETH C0001127602-22-025118
SEC(opens sec.gov)
Nov 74
FRAZIER KENNETH C0001127602-22-025018
SEC(opens sec.gov)
Nov 34
FRAZIER KENNETH C0001127602-22-024871
SEC(opens sec.gov)

Companies

Address

C/O EIKON THERAPEUTICS, INC. 230 HARRIET TUBMAN WAY

MILLBRAE, CA, 94030